Clinical Trials List
2024-06-01 - 2027-12-31
Phase III
Recruiting4
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Shien Wen Division of Cardiovascular Diseases
- 陳俊吉 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李文煌 Division of General Internal Medicine
- Po-Sheng Chen Division of General Internal Medicine
- 張獻元 Division of General Internal Medicine
- 黃鼎鈞 Division of General Internal Medicine
- Po-Tseng Lee Division of General Internal Medicine
- 陳柏偉 Division of General Internal Medicine
- 柯呈諭 Division of General Internal Medicine
- 黃睦翔 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 江君揚 Division of General Internal Medicine
- LIAN-YU LIN Division of General Internal Medicine
- 柯宗佑 Division of General Internal Medicine
- 賀立婷 Division of General Internal Medicine
- 蔡承烜 無
- 王植賢 Division of General Internal Medicine
- JEN-KUANG LEE Division of General Internal Medicine
- MAO-HSIN LIN Division of General Internal Medicine
- 陳盈憲 Division of General Internal Medicine
- Chih-Fan Yeh Division of General Internal Medicine
- Tzung-Dau Wang Division of General Internal Medicine
- CHO-KAI WU Division of General Internal Medicine
- YEN-HUNG LIN Division of General Internal Medicine
- Hsien Li Kao Division of General Internal Medicine
- CHIEN-HUA HUANG Division of General Internal Medicine
- 鄭人方 Division of General Internal Medicine
- Yi-Chih Wang Division of General Internal Medicine
- Chau-Chung Wu Division of General Internal Medicine
- 林柏志 Division of General Internal Medicine
- WEI-TIEN CHANG Division of General Internal Medicine
- 黃慶昌 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳崇暉 Division of Endocrinology
- 蘇冠伃 Division of Endocrinology
- Chin-Sung Kuo Division of Endocrinology
- 蘇冠伃 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
300 participants